EA201790461A1 - COMPOSITIONS OF THE OUT-CELL MATRIX - Google Patents

COMPOSITIONS OF THE OUT-CELL MATRIX

Info

Publication number
EA201790461A1
EA201790461A1 EA201790461A EA201790461A EA201790461A1 EA 201790461 A1 EA201790461 A1 EA 201790461A1 EA 201790461 A EA201790461 A EA 201790461A EA 201790461 A EA201790461 A EA 201790461A EA 201790461 A1 EA201790461 A1 EA 201790461A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compositions
cell matrix
vkm
application
discusses
Prior art date
Application number
EA201790461A
Other languages
Russian (ru)
Inventor
Мохит Б. Бхатиа
Юри Херцберг
Александр КАПЛУНОВСКИЙ
Райана Зака
Цянь Е
Original Assignee
ЭйчЭлАй СЕЛЛЬЮЛАР ТЕРАПЬЮТИКС, ЭлЭлСи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ЭйчЭлАй СЕЛЛЬЮЛАР ТЕРАПЬЮТИКС, ЭлЭлСи filed Critical ЭйчЭлАй СЕЛЛЬЮЛАР ТЕРАПЬЮТИКС, ЭлЭлСи
Publication of EA201790461A1 publication Critical patent/EA201790461A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

В настоящей заявке предлагаются композиции внеклеточного матрикса (ВКМ) и способы их приготовления. Кроме того, в настоящей заявке также рассматривается порядок применения композиций ВКМ, приведённых в настоящем документе.In this application offers the composition of the extracellular matrix (VKM) and methods for their preparation. In addition, this application also discusses how to apply VKM compositions given in this document.

EA201790461A 2014-08-25 2015-08-25 COMPOSITIONS OF THE OUT-CELL MATRIX EA201790461A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462041468P 2014-08-25 2014-08-25
PCT/US2015/046690 WO2016033041A1 (en) 2014-08-25 2015-08-25 Extracellular matrix compositions

Publications (1)

Publication Number Publication Date
EA201790461A1 true EA201790461A1 (en) 2017-07-31

Family

ID=55400430

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201790461A EA201790461A1 (en) 2014-08-25 2015-08-25 COMPOSITIONS OF THE OUT-CELL MATRIX

Country Status (16)

Country Link
US (1) US20170056479A1 (en)
EP (1) EP3185888B1 (en)
JP (3) JP2017525732A (en)
KR (2) KR20170040809A (en)
CN (1) CN106794227B (en)
AU (2) AU2015306811A1 (en)
BR (1) BR112017003905A2 (en)
CA (1) CA2958211C (en)
EA (1) EA201790461A1 (en)
IL (1) IL250753A0 (en)
MX (1) MX2017002469A (en)
MY (1) MY193650A (en)
NZ (1) NZ729021A (en)
SG (2) SG10201901713RA (en)
WO (1) WO2016033041A1 (en)
ZA (1) ZA201701059B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3074089A4 (en) 2013-11-26 2017-07-26 Alliqua Biomedical, Inc. Systems and methods for producing and delivering ultrasonic therapies for wound treatment and healing
JP6712160B2 (en) * 2016-03-29 2020-06-17 株式会社Adeka Pretreatment method for measuring endotoxin and its measuring method
US11318168B2 (en) 2016-06-24 2022-05-03 Osiris Therapeutics, Inc. Human tissue derived compositions and uses thereof
AU2017302612A1 (en) * 2016-07-29 2019-03-14 Alliqua Biomedical, Inc. Systems and methods for delivering cellular and biological materials using ultrasound for wound treatment and healing
CN107349463A (en) * 2017-06-16 2017-11-17 卓阮医疗科技（苏州）有限公司 A kind of biogenic hemostatic micro-granules and preparation method thereof
US11026980B1 (en) * 2018-02-26 2021-06-08 Triad Life Sciences, Inc. Flowable birth tissue composition and related methods
CN109125799A (en) * 2018-09-05 2019-01-04 张强 GelMA hydrogel people takes off the preparation method of the three-dimensional double-deck auxiliary material of cell amnion
CN110841115A (en) * 2019-11-13 2020-02-28 中国科学院遗传与发育生物学研究所 Collagen gel scaffold and application thereof in improving autologous fat cell transplantation survival rate
WO2021242822A1 (en) * 2020-05-26 2021-12-02 Triad Life Sciences, Inc. Modified porcine scaffolds and methods of preparation
JP7189468B2 (en) 2021-01-08 2022-12-14 ダイキン工業株式会社 Defect point estimation system, defect point estimation method, and program

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7615373B2 (en) * 1999-02-25 2009-11-10 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed collagen and tissue engineering
CN1478547A (en) * 2002-08-28 2004-03-03 赵晓红 Collagen protein health protection capsule
US7875273B2 (en) * 2004-12-23 2011-01-25 Ethicon, Incorporated Treatment of Parkinson's disease and related disorders using postpartum derived cells
EP1863547B1 (en) * 2005-03-11 2016-05-11 Wake Forest University Health Sciences Tissue engineered blood vessels
AT502395B1 (en) * 2005-07-27 2007-03-15 Iep Gmbh OXIDOREDUCETASES FOR THE STEREOSELECTIVE REDUCTION OF KETOVER BINDINGS
CN1739797A (en) * 2005-09-06 2006-03-01 易康富生物科技(南通)有限公司 Compound recipe for replenishing collagen
CN102688524A (en) * 2005-10-31 2012-09-26 株式会社现代组织工学 Artificial cartilage containing chondrocytes obtained from costal cartilage and preparation process thereof
NZ576372A (en) * 2006-10-06 2012-02-24 Anthrogenesis Corp Native (telopeptide) placental collagen compositions
US20080279833A1 (en) * 2007-05-10 2008-11-13 Matheny Robert G Laminate sheet articles for tissue regeneration
US20090023885A1 (en) * 2007-07-16 2009-01-22 Texas State University - San Marcos Treatment method for imparting high impact resistance in certain cbdo copolymers
US8198245B2 (en) * 2007-07-27 2012-06-12 Humacyte, Inc. Compositions and methods for soft tissue augmentation
WO2010053918A1 (en) * 2008-11-05 2010-05-14 Hancock Jaffe Laboratories, Inc. Composite containing collagen and elastin as a dermal expander and tissue filler
AU2010249805B2 (en) * 2009-05-20 2015-06-11 Humacyte, Inc. Elastin for soft tissue augmentation
US8652500B2 (en) * 2009-07-22 2014-02-18 Acell, Inc. Particulate tissue graft with components of differing density and methods of making and using the same
CA2771908C (en) * 2009-08-25 2019-05-21 Tissuetech, Inc. Umbilical cord amniotic membrane products
US9908691B2 (en) * 2010-06-30 2018-03-06 Gpcp Ip Holdings Llc Dispenser and sheet product dispensing plate therefor
US8722854B2 (en) * 2010-12-23 2014-05-13 Medskin Solutions Dr. Suwelack Ag Degradation-stabilised, biocompatible collagen matrices
US20120189586A1 (en) * 2011-01-21 2012-07-26 Carl Randall Harrell Human Placental Derived Extracellular Matrix and Uses Therof
KR20210043023A (en) * 2012-09-04 2021-04-20 안트로제네시스 코포레이션 Methods of tissue generation
WO2014089440A1 (en) * 2012-12-07 2014-06-12 Anthrogenesis Corporation Treating oral lesions using placental extracellular matrix
US20150037436A1 (en) * 2013-07-30 2015-02-05 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
JP2017507935A (en) * 2014-02-11 2017-03-23 アントフロゲネシス コーポレーション Microorganoids, and methods for producing and using the same

Also Published As

Publication number Publication date
EP3185888A4 (en) 2018-06-20
AU2015306811A1 (en) 2017-03-09
CN106794227B (en) 2022-03-01
SG10201901713RA (en) 2019-03-28
KR20170040809A (en) 2017-04-13
JP2017525732A (en) 2017-09-07
JP2020142114A (en) 2020-09-10
EP3185888A1 (en) 2017-07-05
NZ729021A (en) 2022-12-23
SG11201701114UA (en) 2017-03-30
JP2022130466A (en) 2022-09-06
MY193650A (en) 2022-10-21
WO2016033041A1 (en) 2016-03-03
CA2958211C (en) 2023-09-26
CA2958211A1 (en) 2016-03-03
EP3185888B1 (en) 2023-06-07
IL250753A0 (en) 2017-04-30
ZA201701059B (en) 2018-04-25
AU2021202201A1 (en) 2021-05-06
CN106794227A (en) 2017-05-31
KR20230129618A (en) 2023-09-08
US20170056479A1 (en) 2017-03-02
BR112017003905A2 (en) 2018-03-06
MX2017002469A (en) 2017-05-19

Similar Documents

Publication Publication Date Title
EA201790461A1 (en) COMPOSITIONS OF THE OUT-CELL MATRIX
PH12018500714A1 (en) Anti-tigit antigen-binding proteins and methods of use thereof
CO2018006662A2 (en) Apeline receptor agonists and methods of use
EA201791460A1 (en) N4-HYDROXYCYTIDINE AND RELATED DERIVATIVES AND OPTIONS FOR ANTI-VIRUS APPLICATION
EA201691988A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
EA201790273A1 (en) FLAGELLIN COMPOSITIONS AND THEIR APPLICATION
EA201692098A1 (en) BIOCERAMIC COMPOSITIONS AND THEIR APPLICATION FOR BIOMODULATION
EA201791485A1 (en) ANTI-CD47-ANTIBODIES AND THEIR APPLICATIONS
EA201692301A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
EA201791029A1 (en) ANTIBODIES AGAINST INTERLEUKIN-33 AND THEIR APPLICATION
MX2015012334A (en) Methods and compositions for weed control.
EA201401077A1 (en) BISPECIFIC ANTIBODIES TO HUMAN TWEAK AND HUMAN IL17 AND THEIR APPLICATION
EA201690280A1 (en) COMPOSITIONS AND METHODS RELATED TO Dedicated ENDOPHITES
EA201591524A1 (en) DERIVATIVES 2-AMINOPYRIMIDINE FOR THE TREATMENT OF VIRAL INFECTIONS
EA201591728A1 (en) HETEROCYCLIC COMPOUNDS AND METHODS OF THEIR APPLICATION
EA201591748A1 (en) P2X7 MODULATORS
EA201491947A1 (en) ANTIBODIES AND IMMUNOCONJUGATES TO LY6E AND METHODS OF APPLICATION
EA201691610A1 (en) ANTI-JAGGED1 ANTIBODIES AND METHODS OF APPLICATION
EA201692269A1 (en) NEW COMPOSITIONS, THEIR USE AND METHODS OF OBTAINING
EA201590731A1 (en) ANTIBODIES TO HEMAGGLUTININ AND METHODS OF APPLICATION
MX2016014862A (en) Her3/her2 bispecific antibodies binding to the beta-hairpin of her3 and domain ii of her2.
PH12019501405A1 (en) Anti-neuropilin antigen-binding proteins and methods of use thereof
EA201691945A1 (en) ANTIBODIES TO HEMAGGLUTININ VIRUS OF TYPE B VIRUS AND METHODS OF THEIR APPLICATION
EA201890810A1 (en) COMPOUNDS EFFECTIVE FOR THE TREATMENT OF HEPATOTOXICITY AND LIVER STEATOSIS AND THEIR APPLICATION
EA201790655A1 (en) NEW ACTIVATORS OF SOLUBLE GUANYLATZCLAZE AND THEIR APPLICATION